Non categorizzato BioNTech, Pfizer to develop single-dose vaccine for COVID, influenza Novembre 3, 2022 0 commenti Pfizer and BioNTech began a study of a single-dose vaccine candidate for influenza and COVID-19, BioNTech said Thursday. The study will combine Pfizer’s quadrivalent modRNA-based influenza vaccin… About the author:
Get involved!
Comments